Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Management of Short Bowel Syndrome/Chronic Intestinal Failure – the Experience of a Single Portuguese Center

Version 1 : Received: 18 February 2024 / Approved: 19 February 2024 / Online: 19 February 2024 (16:24:26 CET)

How to cite: Santos, M.D.; Magalhães, V.; Loureiro, L.; Pina, P.; Castro, A.; Aguiar, P.; Gomes, A.; Soares, D.; Rocha, A. Management of Short Bowel Syndrome/Chronic Intestinal Failure – the Experience of a Single Portuguese Center. Preprints 2024, 2024021018. https://doi.org/10.20944/preprints202402.1018.v1 Santos, M.D.; Magalhães, V.; Loureiro, L.; Pina, P.; Castro, A.; Aguiar, P.; Gomes, A.; Soares, D.; Rocha, A. Management of Short Bowel Syndrome/Chronic Intestinal Failure – the Experience of a Single Portuguese Center. Preprints 2024, 2024021018. https://doi.org/10.20944/preprints202402.1018.v1

Abstract

Aim: To analyze a single center's experience with Short Bowel Syndrome/ Chronic Intestinal Failure (SBS/CIF) in adult patients treated with Home Parenteral Nutrition (HPN). Materials and methods: In the last thirty years, 13 patients with SBS/CIF were included in an HPN program. Results: Between 1992 and 2023, 13 patients were included in an HPN program. The primary underlying pathology was acute mesenteric ischemia. The median age of the starting HPN was 44 years old. Most are submitted to several surgeries of extensive intestinal resection with posterior intestinal reconstruction. Five of the 13 patients have died while on HPN for a median of 42 months. The causes of death HPN-related were catheter sepsis, endocarditis with cardiac failure, or hepatic failure. One patient died due to underlying pathology: pelvic abscesses and bleeding related to radiotherapy. Eight patients remain alive with a median time of HPN of 173 months. During the HPN support, the most frequent complications were venous catheter infection and venous territory thrombosis. None of the eight patients alive have hepatic failure. Two patients recently started teduglutide, with good tolerance, and need reduction of HPN support. All these eight patients have a satisfactory quality of life (parenteral support needs range between five to two nutrition bags per week). Conclusion: HPN remains the gold standard of SBS/CIF treatment, although Teduglutide may reduce HPN needs and HPN complications and provide a better quality of life. An HPN multidisciplinary healthcare group support is essential to ensure these patients' survival and quality of life. Keywords Short bowel Syndrome, Chronic Intestinal failure, Home Parenteral Nutrition, Teduglutide, Complications of Parenteral Support.

Keywords

Keywords; Short bowel Syndrome; Chronic Intestinal failure; Home Parenteral Nutrition; Teduglutide; Complications of Parenteral Support

Subject

Medicine and Pharmacology, Clinical Medicine

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.